To ensure the consistency of qPCR measurements over the time period of the study, the same batches of primers and probes were employed. replication of the computer virus. Purified anti-viral IgGs, but not other soluble factor(s) from heat-inactivated mouse immune serum, were sufficient to enhance contamination. Antibody-mediated contamination was dependent on signaling-competent members of the human FcRII family, which were shown to confer susceptibility to otherwise na?ve ST486 cells, as binding of immune complexes to cell surface FcRII was necessary but not sufficient to induce antibody-dependent enhancement (ADE) of infection. Furthermore, only FcRII with intact cytoplasmic signaling domains were competent to sustain ADE of SARS-CoVpp contamination, thus providing additional information on the role of downstream signaling by FcRII. Conclusions These results demonstrate that human macrophages can be infected by SARS-CoV as a result of IgG-mediated ADE and indicate that this contamination route requires signaling pathways activated downstream of binding to FcRII receptors. Keywords: SARS-CoV, Spike, Antibody-dependent enhancement, Macrophage, Fc receptor, Antibodies, Pseudotypes Background The continuous threat of respiratory viruses to public health was exemplified by the global impact LX-1031 of the SARS-CoV outbreak in 2003 [1], by the occurrence since 2003 of confirmed human cases of H5N1 avian influenza in many countries, particularly across Asia [2], and the 2009 2009 H1N1 influenza pandemic [3]. The recent emergence in the Arab peninsula of a novel coronavirus responsible for the Middle East respiratory syndrome (MERS-CoV), [4,5] and the new H7N9 strain of avian influenza that has jumped into Rabbit Polyclonal to E-cadherin humans [6,7] in China underscore the need to continue work in this direction. It is now agreed that SARS-CoV can infect not only the respiratory tract, but can also affect other organ systems and several reports have exhibited contamination of hematopoietic cells [8-10]; however, the mechanism by which SARS-CoV enters into immune cells, which do not express the SARS-CoV receptor angiotensin-converting enzyme 2 (ACE2) [11,12] has remained poorly comprehended. Both C-type lectin receptors such as liver/lymph node-specific intercellular adhesion molecule-3-grabbing integrin (L-SIGN) or dendritic cell specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) [13,14], as well as antibody-mediated contamination may provide SARS-CoV with an opportunity to change its tropism. Because of the lack of effective antiviral strategies to control coronaviruses infections, vaccination is still regarded as a major option for preventing resurgence of SARS and related diseases. We previously showed that a SARS-CoV vaccine candidate based on recombinant, full-length SARS-CoV Spike-protein trimers brought on infection of human B cell lines despite eliciting in vivo a neutralizing and protective immune response in rodents [15]. More recently, we exhibited that anti-Spike antibody potentiates contamination of both monocytic and lymphoid immune cell lines, not only by SARS-CoVpp but also by replication-competent SARS-coronavirus [16], thus providing evidence for a novel and versatile mechanism by which SARS-CoV can enter into target cells that do not express the conventional ACE2 computer virus receptor and are otherwise refractory to the computer virus. Such contamination pathway may have implications for understanding the tropism and pathogenesis of LX-1031 the computer virus and, therefore, we further investigated the molecular and cellular mechanisms underlying ADE of SARS-CoV LX-1031 contamination. By monitoring the susceptibility of human bulk primary immune cells (i.e. peripheral blood mononuclear cells) we have established the occurrence of ADE of SARS-CoVpp contamination in different circulating immune cell types, among which the monocytic lineage (CD68+ cells) was the primary target. In addition to monocytes, human macrophages were also infected by SARS-CoV in presence of.